Clinical Characteristics and Managements of Primary Open-Angle Glaucoma Patients at National Eye Center, Cicendo Eye Hospital, Bandung, Indonesia

Azmi I Salsabila; Andika P Gandasubrata; Maula Rifada

doi:10.28932/jmh.v5i1.4265

Authors

Azmi I Salsabila Universitas Padjadjaran
Andika P Gandasubrata Universitas Padjadjaran
Maula Rifada Universitas Padjadjaran

DOI:

https://doi.org/10.28932/jmh.v5i1.4265

Keywords:

characteristic, glaucoma medication, glaucoma surgery, management, primary open-angle glaucoma

Abstract

Glaucoma is the largest cause of permanent blindness globally. Primary open-angle glaucoma (POAG) is one of chronic glaucoma and is asymptomatic in the early stage. This study was performed to identify the clinical characteristics and management of POAG patients at the Cicendo Eye Hospital, Bandung, Indonesia. This retrospective, descriptive study was conducted on medical records of POAG patients in Cicendo Eye Hospital in January-December 2020 using whole sampling method. Sociodemographic, clinical characteristics, and management data were collected. From 147 subjects obtained, the largest age group of POAG patients was 60-69 years old (30.6%), with most of the patients being male (68.0%). Most of the patients experienced blindness (37.6%) and had cup-to-disc ratio (CDR) 0.9-1.0 (36.8%). The mean of pre-treatment IOP was 29.1±13.1 mmHg, and the mean of post-treatment was 19.3±7.7 mmHg. The mean of anti-glaucoma medication in the first and the last control were 1.93±0.59 and 1.48±0.70, respectively. The most common treatments were medication only (69.8%), with combined surgery as the most performed surgery. In conclusion, most POAG patients were 60 years old or older and male, with most eyes being blind. The POAG treatments were mostly anti-glaucoma medication only to lower IOP as the goals of the treatment.

Downloads

Download data is not yet available.

References

Bourne RRA, Steinmetz JD, Saylan M, Mersha AM, Weldemariam AH, Wondmeneh TG, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study. Lancet Glob Heal. 2021;9(2):e144–60.

Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis. Am Acad Opthalmology. 2014;121(11):2081–90.

Chan EWE, Li X, Tham YC, Liao J, Wong TY, Aung T, et al. Glaucoma in Asia: Regional prevalence variations and future projections. Br J Ophthalmol. 2016;100(1):78–85.

Rachmawati M, Rini M, Halim A. Blindness and Visual Impairment Profile of Rapid Assessment of Avoidable Blindness in Indonesia. 2019;1–15.

Cantor LB, Rapuano CJ, McCannel CA. Basic and Clinical Course of Glaucoma. San Fransisco: Am Acad Opthalmology. 2020; 235.

Cvenkel B, Kolko M. Current Medical Therapy and Future Trends in the Management of Glaucoma Treatment. J Ophthalmol. 2020;2020(1).

Ilahi F, Vera V. Tampilan Klinis pada Glaukoma Primer Sudut Terbuka di RSUP DR M Djamil Padang. J Kesehat Andalas. 2018;7(Supplement 1):1.

Pan CW, Yang WY, Hu DN, Xu JG, Niu ZQ, Yuan YS, et al. Longitudinal Cohort Study on the Incidence of Primary Open-Angle Glaucoma in Bai Chinese. Am J Ophthalmol. 2017;176:127–33.

Khurana A. Comprehensive Ophthalmology. 6th ed. New Delhi: Jaypee Brothers Medical Publisher (P) Ltd; 2015.p 610.

Alzuhairy S, Alalola FS, AlAkeel HA, Alayed DM, Al-Harbi IM, Al-Shetwi MM, et al. Profile and management outcomes of glaucoma cases at Qassim University Hospital. Int J Health Sci (Qassim). 2018;12(5):20–4.

Khachatryan N, Pistilli M, Maguire MG, Salowe RJ, Fertig RM, Moore T, et al. Primary open-angle African American Glaucoma Genetics (POAAGG) study: Gender and risk of POAG in African Americans. PLoS One. 2019;14(8):1–11.

Pai V, Thota RS. Ocular Biometry in Patients with Primary Open Angle Glaucoma ( POAG ). J Eye Dis Disord. 2017;2(1):2–4.

Ribeiro L dos MG, Freitas RF, Ribeiro LMG, Silveira MF, Leite MT de S. Clinical and epidemiological study in patients with primary open-angle glaucoma. Rev Bras Oftalmol. 2018;77(1):9–13.

Bowe A, Grünig M, Schubert J, Demir M, Hoffmann V, Kütting F, et al. Circadian Variation in Arterial Blood Pressure and Glaucomatous Optic Neuropathy - A Systematic Review and Meta-Analysis. Am J Hypertens. 2015;28(9):1077–82.

Zhao D, Cho J, Kim MH, Guallar E. The association of blood pressure and primary open-angle glaucoma: a meta-analysis. Am J Ophthalmol. 2014;158(3):615-27.e9.

Zhou M, Wang W, Huang W, Zhang X. Diabetes mellitus as a risk factor for open-angle glaucoma: A systematic review and meta-analysis. PLoS One. 2014;9(8).

Zhao YX, Chen XW. Diabetes and risk of glaucoma: Systematic review and a meta-analysis of prospective cohort studies. Int J Ophthalmol. 2017;10(9):1430–5.

Paul C, Sengupta S, Banerjee S, Choudhury S. Open-angle glaucoma in a rural and urban population in Eastern India—the Hooghly river glaucoma study. Indian J Ophthalmol. 2020;68(2):371–374.

Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in northern Nigeria: Stage at presentation and acceptance of treatment. BMC Ophthalmol. 2015;15(1):1–8.

Chuka Okosa M, Ijeoma Apakama A, Anthony Onwuegbuna A, Charles Uzozie C, Chika Amobi MB, Obizoba Onyekwe L, et al. Clinical features of Primary Open Angle Glaucoma at initial presentation: Experience at a tertiary eye care center in Nigeria. J Ophthalmol Res. 2021;04(03):244–53.

Marchini G, Ceruti P, Vizzari G, Berzaghi D, Zampieri A. Management of Concomitant Cataract and Glaucoma. Dev Ophthalmol. 2017;59:155–64.

Talaat K, Fathi OT, Alamoudi SM, Alzahrani MG, Mukhtar RM, Khan MA. Types of Glaucoma and Associated Comorbidities Among Patients at King Abdulaziz Medical City, Jeddah. Cureus. 2021;13(6).

Duke R, Akinye A, Ameh S. Presenting visual acuity and ocular comorbidity in patients with primary open angle glaucoma in a private tertiary eye center in Nigeria. J Curr Glaucoma Pract. 2013;7(1):6–10.

Gyasi ME, Andrew F, Adjuik M, Kesse E, Kodjo RA, Herndon L. The effect of medical therapy on IOP control in Ghana. Ghana Med J. 2014;48(3):148–52.

Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: A review. JAMA - J Am Med Assoc. 2014;311(18):1901–11.

Jiang L, Eaves S, Dhillon N, Ranjit P. Postoperative outcomes following trabeculectomy and nonpenetrating surgical procedures: A 5-year longitudinal study. Clin Ophthalmol. 2018;12:995–1002.

Garris winston J, Le D, Zurakowski D, Ayyala RS. Comparison of surgical outcomes between canaloplasty and trabeculectomy with mitomycin C at 2 year follow up: A longitudinal cohort study. Indian J Ophthalmol. 2017;17(1):1.

Jung JL, Isida-Llerandi CG, Lazcano-Gomez G, Soohoo JR, Kahook MY. Intraocular pressure control after trabeculectomy, phacotrabeculectomy and phacoemulsification in a hispanic population. J Curr Glaucoma Pract. 2014;8(2):67–74.

Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Treatment Outcomes in the Tube Versus Trabeculectomy (TVT) Study After Five Years of Follow-up. Am J Ophthalmol. 2012;153(3):789–803.e2.

Chen HY, Lin CL, Kao CH. Changes in glaucoma medication numbers after cataract and glaucoma surgery : A nationwide population-based study. Med (United States). 2019;98(4):0–5.

Majstruk L, Leray B, Bouillot A, Michée S, Sultan G, Baudouin C, et al. Long term effect of phacoemulsification on intraocular pressure in patients with medically controlled primary open-angle glaucoma. BMC Ophthalmol. 2019;19(1):1–7.